AICDA |
Q9GZX7
|
activation induced cytidine deaminase
|
Enzyme
|
9.2E-06 |
0.463 |
0.885 |
AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
BCL6 |
P41182
|
BCL6 transcription repressor
|
|
0.96 |
0.444 |
0.808 |
CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
CD19 |
P15391
|
CD19 molecule
|
|
0.90 |
0.430 |
0.885 |
CD200 |
P41217
|
CD200 molecule
|
|
0.41 |
0.529 |
0.769 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
CXCR4 |
P61073
|
C-X-C motif chemokine receptor 4
|
G-protein coupled receptor
|
1.8E-02 |
0.362 |
0.923 |
FCER2 |
P06734
|
Fc fragment of IgE receptor II
|
Receptor
|
7.6E-12 |
0.560 |
0.654 |
IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |
IGHV3OR16-7 |
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene)
|
|
|
0.566 |
0.654 |
IL2RA |
P01589
|
interleukin 2 receptor subunit alpha
|
Receptor
|
5.5E-02 |
0.389 |
0.885 |
IRF4 |
Q15306
|
interferon regulatory factor 4
|
Transcription factor
|
0.86 |
0.491 |
0.769 |
KRT20 |
P35900
|
keratin 20
|
|
9.1E-11 |
0.388 |
0.846 |
LOC102723407 |
|
immunoglobulin heavy variable 4-38-2-like
|
|
|
0.514 |
0.769 |
LOC102724971 |
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
|
|
0.527 |
0.769 |
LPL |
P06858
|
lipoprotein lipase
|
Enzyme
|
1.3E-09 |
0.474 |
0.808 |
MALT1 |
Q9UDY8
|
MALT1 paracaspase
|
Enzyme
|
0.99 |
0.532 |
0.769 |
MCL1 |
Q07820
|
MCL1 apoptosis regulator, BCL2 family member
|
Signaling
|
0.96 |
0.430 |
0.808 |
MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
MS4A1 |
P11836
|
membrane spanning 4-domains A1
|
Receptor
|
5.1E-05 |
0.411 |
0.846 |
MYC |
P01106
|
MYC proto-oncogene, bHLH transcription factor
|
Transcription factor
|
1.00 |
0.344 |
0.923 |